Cargando…

Transcription factors CP2 and YY1 as prognostic markers in head and neck squamous cell carcinoma: analysis of The Cancer Genome Atlas and a second independent cohort

PURPOSE: The transcription factors YY1 and CP2 have been associated with tumor promotion and suppression in various cancers. Recently, simultaneous expression of both markers was correlated with negative prognosis in cancer. The aim of this study was to explore the expression of YY1 and CP2 in head...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schnoell, Julia, Jank, Bernhard J., Kadletz-Wanke, Lorenz, Stoiber, Stefan, Spielvogel, Clemens P., Gurnhofer, Elisabeth, Kenner, Lukas, Heiduschka, Gregor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article – Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872999/ https://www.ncbi.nlm.nih.gov/pubmed/33315124 http://dx.doi.org/10.1007/s00432-020-03482-6

Ejemplares similares

Protein Expression of Folate Receptor Alpha in Adenoid Cystic Carcinoma of the Head and Neck
por: Schnoell, Julia, et al.
Publicado: (2022)

Prognostic Relevance of Thyroid-Hormone-Associated Proteins in Adenoid Cystic Carcinoma of the Head and Neck
por: Schnoell, Julia, et al.
Publicado: (2021)

β-CATENIN is a positive prognostic marker for HPV-positive head and neck squamous cell carcinoma
por: Stoiber, Stefan, et al.
Publicado: (2023)

µ-Crystallin Is Associated with Disease Outcome in Head and Neck Squamous Cell Carcinoma
por: Jank, Bernhard J., et al.
Publicado: (2021)

The prognostic role of PSMD14 in head and neck squamous cell carcinoma
por: Schnoell, Julia, et al.
Publicado: (2022)

Targeting Wnt/Beta-Catenin Signaling in HPV-Positive Head and Neck Squamous Cell Carcinoma
por: Brkic, Faris F., et al.
Publicado: (2022)

Inhibition of beta-catenin shows therapeutic potential in head and neck squamous cell carcinoma in vitro
por: Maier, Tobias, et al.
Publicado: (2022)

High USP4 mRNA is associated with an HPV-positive status in head and neck squamous cell carcinoma patients
por: Scheiflinger, Alexandra, et al.
Publicado: (2023)

Overexpression of LAPTM4B-35 is a negative prognostic factor in head and neck squamous cell carcinoma
por: Kotowski, Ulana, et al.
Publicado: (2019)

Radiogenomic markers enable risk stratification and inference of mutational pathway states in head and neck cancer
por: Spielvogel, Clemens P., et al.
Publicado: (2022)

Radiosensitizing effect of galunisertib, a TGF-ß receptor I inhibitor, on head and neck squamous cell carcinoma in vitro
por: Jank, Bernhard J., et al.
Publicado: (2022)

Expression of inhibitors of apoptosis proteins in salivary gland adenoid cystic carcinoma: XIAP is an independent marker of impaired cause‐specific survival
por: Schnoell, Julia, et al.
Publicado: (2020)

The ATR inhibitor berzosertib acts as a radio- and chemosensitizer in head and neck squamous cell carcinoma cell lines
por: Schnoell, Julia, et al.
Publicado: (2023)

The radiosensitizing effect of β-Thujaplicin, a tropolone derivative inducing S-phase cell cycle arrest, in head and neck squamous cell carcinoma-derived cell lines
por: Haas, Markus, et al.
Publicado: (2022)

AF1q Expression Associates with CD44 and STAT3 and Impairs Overall Survival in Adenoid Cystic Carcinoma of the Head and Neck
por: Kadletz, Lorenz C., et al.
Publicado: (2019)

Evaluation of the Prognostic Capacity of a Novel Survival Marker in Patients with Sinonasal Squamous Cell Carcinoma
por: Brkic, Faris F., et al.
Publicado: (2022)

The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck Cancer
por: Haas, Markus, et al.
Publicado: (2023)

Early on-treatment C-reactive protein and its kinetics predict survival and response in recurrent and/or metastatic head and neck cancer patients receiving first-line pembrolizumab
por: Haas, Markus, et al.
Publicado: (2023)

The Potential Prognostic Value of a Novel Hematologic Marker Fibrinogen-to-Lymphocyte Ratio in Head and Neck Adenoid-Cystic Carcinoma
por: Brkic, Faris F., et al.
Publicado: (2021)

In vitro effects of gamma-secretase inhibition in HPV-positive and HPV-negative head and neck squamous cell carcinoma
por: Varatanovic, Sara, et al.
Publicado: (2023)

Zerumbone acts as a radiosensitizer in head and neck squamous cell carcinoma
por: Schnoell, Julia, et al.
Publicado: (2021)

Evaluation of the External Jugular Vein Overlying the Sternocleidomastoid Muscle as Venous Lymph-Node Flap
por: Kadletz-Wanke, Lorenz, et al.
Publicado: (2022)

In vitro antineoplastic effects of MK0752 in HPV-positive head and neck squamous cell carcinoma
por: Varatanovic, Sara, et al.
Publicado: (2023)

Analysis of Perioperative Platelet Indices and Their Prognostic Value in Head and Neck Cancer Patients Treated with Surgery and Postoperative Radiotherapy: A Retrospective Cohort Study
por: Jank, Bernhard J., et al.
Publicado: (2019)

Pretherapeutic Serum Albumin as an Outcome Prognosticator in Head and Neck Adenoid-Cystic Carcinoma
por: Friedl, Marlene, et al.
Publicado: (2022)

Potential association of the prognostic index and survival in patients with p16-positive oropharyngeal squamous cell carcinoma
por: Brkic, Faris F., et al.
Publicado: (2021)

Correction to: Potential association of the prognostic index and survival in patients with p16-positive oropharyngeal squamous cell carcinoma
por: Brkic, Faris F., et al.
Publicado: (2021)

Survival prognostic factors for metachronous second primary head and neck squamous cell carcinoma
por: Chen, Jin‐Hua, et al.
Publicado: (2016)

YY1 directly suppresses MYCT1 leading to laryngeal tumorigenesis and progress
por: Qu, Si‐Yao, et al.
Publicado: (2017)

YY1 and CP2c in Unidirectional Spermatogenesis and Stemness
por: Cheon, Yong-Pil, et al.
Publicado: (2020)

PRKCA Overexpression Is Frequent in Young Oral Tongue Squamous Cell Carcinoma Patients and Is Associated with Poor Prognosis
por: Parzefall, Thomas, et al.
Publicado: (2021)

FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma
por: Liang, Huazhen, et al.
Publicado: (2021)

FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis
por: Huang, Junjie, et al.
Publicado: (2021)

ADAM8 in squamous cell carcinoma of the head and neck: a retrospective study
por: Zielinski, Valerie, et al.
Publicado: (2012)

Identification of hub methylated‐CpG sites and associated genes in oral squamous cell carcinoma
por: Dai, Yuxin, et al.
Publicado: (2020)

Impact of Sonic Hedgehog Pathway Expression on Outcome in HPV Negative Head and Neck Carcinoma Patients after Surgery and Adjuvant Radiotherapy
por: Enzenhofer, Elisabeth, et al.
Publicado: (2016)

Tumour stage and gender predict recurrence and second primary malignancies in head and neck cancer: a multicentre study within the INHANCE consortium
por: Leoncini, Emanuele, et al.
Publicado: (2018)

ELMO3 – a Negative Prognostic Marker in Minor Salivary Gland Carcinoma
por: Kotowski, Ulana, et al.
Publicado: (2018)

Low SOX2 expression marks a distinct subset of adenoid cystic carcinoma of the head and neck and is associated with an advanced tumor stage
por: Thierauf, Julia, et al.
Publicado: (2018)

Diagnostic and prognostic relevance of CP2c and YY1 expression in hepatocellular carcinoma
por: Kim, Ji Sook, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u9v8sulcvtpgk6l7slg5km0cjo